No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
65 |
4. Check minimum number of eventsNone |
65 |
5. Include endpointsNone |
65 |
6. Filter based on genotype QC (FinnGen only) |
61 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Rhabdomyosarcoma, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, wide definition for exclusion
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 61 | 29 | 32 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 41.82 | 44.53 | 39.37 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 65
- Matched controls
- 650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A98, ,
ICD-O-3
+∞
75.4
57
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
68.2
53
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
66.5
52
*
WX110, ,
ICD-O-3
+∞
58.4
47
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
56.8
46
*
J01DB01, ,
ATC
cefalexin; oral
+∞
56.8
46
*
GD1AA, ,
ICD-O-3
+∞
52.3
43
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
48.0
40
*
130, ,
Kela drug reimbursment
Malignant tumour
+∞
46.5
39
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
46.5
39
*
ZXD10, ,
ICD-O-3
+∞
45.1
38
*
R4110, ,
ICD-O-3
+∞
43.8
37
*
ZXE00, ,
ICD-O-3
+∞
42.4
36
*
WZC00, ,
ICD-O-3
+∞
42.4
36
*
SAA01, ,
ICD-O-3
+∞
41.0
35
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
38.4
33
*
ZXE10, ,
ICD-O-3
+∞
37.1
32
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
37.1
32
*
SAA02, ,
ICD-O-3
+∞
34.5
30
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
34.5
30
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
34.5
30
*
S18, ,
ICD-O-3
+∞
33.2
29
*
EB1HA, ,
ICD-O-3
+∞
33.2
29
*
Z2221, ,
ICD-O-3
+∞
31.9
28
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
30.7
27
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
30.7
27
*
WX408, ,
ICD-O-3
+∞
30.7
27
*
A04AA01, ,
ATC
ondansetron; systemic, rectal
+∞
30.7
27
*
SAA03, ,
ICD-O-3
+∞
30.7
27
*
ZXA00, ,
ICD-O-3
+∞
29.4
26
*
SFA20, ,
ICD-O-3
+∞
29.4
26
*
H02AB02, ,
ATC
dexamethasone; systemic
+∞
28.2
25
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
28.2
25
*
GD1UA, ,
ICD-O-3
+∞
28.2
25
*
J01DA01, ,
ATC
[U] cefalexin
+∞
28.2
25
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
28.2
25
*
GD1BD, ,
ICD-O-3
+∞
26.9
24
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
26.9
24
*
K021, ,
ICD-O-3
+∞
26.9
24
*
ZXD05, ,
ICD-O-3
+∞
25.7
23
*
WX404, ,
ICD-O-3
+∞
25.7
23
*
EB1AA, ,
ICD-O-3
+∞
24.5
22
*
Z3231, ,
ICD-O-3
+∞
24.5
22
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
24.5
22
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
23.3
21
*
EB1SA, ,
ICD-O-3
+∞
23.3
21
*
TPH15, ,
ICD-O-3
+∞
23.3
21
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
23.3
21
*
SFA10, ,
ICD-O-3
+∞
23.3
21
*
WX402, ,
ICD-O-3
+∞
23.3
21
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
22.1
20
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
22.1
20
*
ZX012, ,
ICD-O-3
+∞
22.1
20
*
SPAT1249, ,
ICD-O-3
+∞
22.1
20
*
ZXA05, ,
ICD-O-3
+∞
22.1
20
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
22.1
20
*
M03BX02, ,
ATC
tizanidine; oral
+∞
22.1
20
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
22.1
20
*
N05CF01, ,
ATC
zopiclone; oral
+∞
22.1
20
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
22.1
20
*
J069, ,
ICD-O-3
+∞
21.0
19
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
21.0
19
*
KMAK, ,
ICD-O-3
+∞
21.0
19
*
ZXE20, ,
ICD-O-3
+∞
21.0
19
*
SDA02, ,
ICD-O-3
+∞
21.0
19
*
Z3226, ,
ICD-O-3
+∞
21.0
19
*
SCA01, ,
ICD-O-3
+∞
21.0
19
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
21.0
19
*
E0000UV, ,
ATC
+∞
21.0
19
*
L03AA02, ,
ATC
filgrastim; parenteral
+∞
21.0
19
*
TPH04, ,
ICD-O-3
+∞
19.8
18
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
19.8
18
*
L03AA13, ,
ATC
pegfilgrastim; parenteral
+∞
19.8
18
*
I10, ,
ICD-O-3
+∞
19.8
18
*
-1, ,
ICD-O-3
+∞
19.8
18
*
JN4BD, ,
ICD-O-3
+∞
19.8
18
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
19.8
18
*
XF400, ,
ICD-O-3
+∞
19.8
18
*
SPAT1256, ,
ICD-O-3
+∞
18.6
17
*
FM1AE, ,
ICD-O-3
+∞
18.6
17
*
WW500, ,
ICD-O-3
+∞
18.6
17
*
Z012, ,
ICD-O-3
+∞
18.6
17
*
SPAT1312, ,
ICD-O-3
+∞
17.5
16
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
17.5
16
*
JN3AE, ,
ICD-O-3
+∞
17.5
16
*
SDA03, ,
ICD-O-3
+∞
17.5
16
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
17.5
16
*
N03AX16, ,
ATC
[U] pregabalin
+∞
17.5
16
*
R06AE07, ,
ATC
cetirizine; oral
+∞
17.5
16
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
17.5
16
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
16.3
15
*
TPH90, ,
ICD-O-3
+∞
16.3
15
*
SPAT1263, ,
ICD-O-3
+∞
16.3
15
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
16.3
15
*
R2130, ,
ICD-O-3
+∞
16.3
15
*
SPAT1253, ,
ICD-O-3
+∞
16.3
15
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
16.3
15
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
16.3
15
*
TPH07, ,
ICD-O-3
+∞
16.3
15
*
WX002, ,
ICD-O-3
+∞
16.3
15
*
SPAT1153, ,
ICD-O-3
+∞
16.3
15
*
WX290, ,
ICD-O-3
+∞
16.3
15
*
WD125, ,
ICD-O-3
+∞
16.3
15
*
WYA05, ,
ICD-O-3
+∞
15.2
14
*
WF002, ,
ICD-O-3
+∞
15.2
14
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
15.2
14
*
WZB00, ,
ICD-O-3
+∞
15.2
14
*
GD1AD, ,
ICD-O-3
+∞
15.2
14
*
SPAT1325, ,
ICD-O-3
+∞
15.2
14
*
SPAT1301, ,
ICD-O-3
+∞
15.2
14
*
M796, ,
ICD-O-3
+∞
15.2
14
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
15.2
14
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
15.2
14
*
XW000, ,
ICD-O-3
+∞
15.2
14
*
D07AC01, ,
ATC
betamethasone; topical
+∞
15.2
14
*
N05BA04, ,
ATC
oxazepam; oral
+∞
15.2
14
*
Z515, ,
ICD-10 Finland
Palliative care
+∞
14.0
13
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
14.0
13
*
SFA30, ,
ICD-O-3
+∞
14.0
13
*
Z012, ,
ICD-10 Finland
Dental examination
+∞
14.0
13
*
R01AD09, ,
ATC
mometasone; nasal
+∞
14.0
13
*
AA1AD, ,
ICD-O-3
+∞
14.0
13
*
EBA00, ,
ICD-O-3
+∞
14.0
13
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
14.0
13
*
ZX120, ,
ICD-O-3
+∞
14.0
13
*
WX700, ,
ICD-O-3
+∞
12.9
12
*
R4120, ,
ICD-O-3
+∞
12.9
12
*
Z712, ,
ICD-O-3
+∞
12.9
12
*
C10AA01, ,
ATC
simvastatin; oral
+∞
12.9
12
*
JN4AD, ,
ICD-O-3
+∞
12.9
12
*
D19, ,
ICD-O-3
+∞
12.9
12
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
12.9
12
*
D07AC13, ,
ATC
mometasone; topical
+∞
12.9
12
*
Z035, ,
ICD-10 Finland
Observation for other suspected cardiovascular diseases
+∞
12.9
12
*
A419, ,
ICD-10 Finland
Sepsis, unspecified
+∞
12.9
12
*
NG1AA, ,
ICD-O-3
+∞
12.9
12
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
12.9
12
*
FM1EE, ,
ICD-O-3
+∞
12.9
12
*
D01BA02, ,
ATC
terbinafine; oral
+∞
12.9
12
*
TPX10, ,
ICD-O-3
+∞
12.9
12
*
R83, ,
ICD-O-3
+∞
12.9
12
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
12.9
12
*
Z871, ,
ICD-O-3
+∞
11.8
11
*
GD1QA, ,
ICD-O-3
+∞
11.8
11
*
WX602, ,
ICD-O-3
+∞
11.8
11
*
HA1AE, ,
ICD-O-3
+∞
11.8
11
*
SPAT1315, ,
ICD-O-3
+∞
11.8
11
*
S29, ,
ICD-O-3
+∞
11.8
11
*
C03CA01, ,
ATC
furosemide; systemic
+∞
11.8
11
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
11.8
11
*
SPAT1250, ,
ICD-O-3
+∞
11.8
11
*
QX3HE, ,
ICD-O-3
+∞
11.8
11
*
JN1AE, ,
ICD-O-3
+∞
11.8
11
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
11.8
11
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
11.8
11
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
11.8
11
*
A28, ,
ICD-O-3
+∞
11.8
11
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
11.8
11
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
11.8
11
*
C4904, ,
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck rhabdomyosarcoma
+∞
11.8
11
*
SPAT1310, ,
ICD-O-3
+∞
11.8
11
*
R4190, ,
ICD-O-3
+∞
11.8
11
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
11.8
11
*
WD105, ,
ICD-O-3
+∞
11.8
11
*
D82, ,
ICD-O-3
+∞
11.8
11
*
A04AA02, ,
ATC
granisetron; systemic, transdermal
+∞
11.8
11
*
WB123, ,
ICD-O-3
+∞
11.8
11
*
WZC30, ,
ICD-O-3
+∞
11.8
11
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
11.8
11
*
K0364, ,
ICD-O-3
+∞
11.8
11
*
HA1AA, ,
ICD-O-3
+∞
10.7
10
*
S21, ,
ICD-O-3
+∞
10.7
10
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
10.7
10
*
R74, ,
ICD-O-3
+∞
10.7
10
*
SDA04, ,
ICD-O-3
+∞
10.7
10
*
K020, ,
ICD-10 Finland
Caries limited to enamel
+∞
10.7
10
*
TQX10, ,
ICD-O-3
+∞
10.7
10
*
D481, ,
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
+∞
10.7
10
*
159, ,
Kela drug reimbursment
Pazopanib
+∞
10.7
10
*
UJD10, ,
ICD-O-3
+∞
10.7
10
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
10.7
10
*
C09CA01, ,
ATC
losartan; oral
+∞
10.7
10
*
N02AB03, ,
ATC
fentanyl; nasal, sublingual, transdermal
+∞
10.7
10
*
Z2446, ,
ICD-O-3
+∞
10.7
10
*
ZXE30, ,
ICD-O-3
+∞
10.7
10
*
UJF32, ,
ICD-O-3
+∞
10.7
10
*
SCA02, ,
ICD-O-3
+∞
10.7
10
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
10.7
10
*
K021, ,
ICD-10 Finland
Caries of dentine
+∞
10.7
10
*
SDA01, ,
ICD-O-3
+∞
10.7
10
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
10.7
10
*
AA1CG, ,
ICD-O-3
+∞
10.7
10
*
N05BA06, ,
ATC
lorazepam; systemic, sublingual
+∞
10.7
10
*
SPAT1223, ,
ICD-O-3
+∞
10.7
10
*
PH2AE, ,
ICD-O-3
+∞
9.6
9
*
M545, ,
ICD-O-3
+∞
9.6
9
*
LC2BE, ,
ICD-O-3
+∞
9.6
9
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
9.6
9
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
9.6
9
*
L08, ,
ICD-O-3
+∞
9.6
9
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
9.6
9
*
WB103, ,
ICD-O-3
+∞
9.6
9
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
9.6
9
*
A06AD11, ,
ATC
lactulose; oral
+∞
9.6
9
*
NFR30, ,
ICD-O-3
+∞
9.6
9
*
Z3229, ,
ICD-O-3
+∞
9.6
9
*
WB113, ,
ICD-O-3
+∞
9.6
9
*
ZX112, ,
ICD-O-3
+∞
9.6
9
*
B01AA03, ,
ATC
warfarin; systemic
+∞
9.6
9
*
ZX090, ,
ICD-O-3
+∞
9.6
9
*
A03, ,
ICD-O-3
+∞
9.6
9
*
A04AD12, ,
ATC
aprepitant; systemic
+∞
9.6
9
*
NE1CG, ,
ICD-O-3
+∞
9.6
9
*
C4954, ,
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis rhabdomyosarcoma
+∞
9.6
9
*
WX302, ,
ICD-O-3
+∞
9.6
9
*
C09AA05, ,
ATC
ramipril; oral
+∞
9.6
9
*
ZXE04, ,
ICD-O-3
+∞
9.6
9
*
L17, ,
ICD-O-3
+∞
9.6
9
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
9.6
9
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
9.6
9
*
Z001, ,
ICD-O-3
+∞
9.6
9
*
C4939, ,
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
9.6
9
*
C4924, ,
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip rhabdomyosarcoma
+∞
9.6
9
*
ZXE03, ,
ICD-O-3
+∞
9.6
9
*
B01AB10, ,
ATC
tinzaparin; parenteral
+∞
9.6
9
*
L03, ,
ICD-O-3
+∞
9.6
9
*
N06AB10, ,
ATC
escitalopram; oral
+∞
9.6
9
*
C08CA01, ,
ATC
amlodipine; oral
+∞
9.6
9
*
XX3DW, ,
ICD-O-3
+∞
9.6
9
*
WZA90, ,
ICD-O-3
+∞
8.5
8
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
8.5
8
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
8.5
8
*
A97, ,
ICD-O-3
+∞
8.5
8
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
8.5
8
*
FM1DE, ,
ICD-O-3
+∞
8.5
8
*
TAB00, ,
ICD-O-3
+∞
8.5
8
*
SPAT1216, ,
ICD-O-3
+∞
8.5
8
*
QX3AT, ,
ICD-O-3
+∞
8.5
8
*
ZXA10, ,
ICD-O-3
+∞
8.5
8
*
WF003, ,
ICD-O-3
+∞
8.5
8
*
WX892, ,
ICD-O-3
+∞
8.5
8
*
Z508, ,
ICD-10 Finland
Care involving use of other rehabilitation procedures
+∞
8.5
8
*
Z011, ,
ICD-10 Finland
Examination of ears and hearing
+∞
8.5
8
*
K020, ,
ICD-O-3
+∞
8.5
8
*
ZY010, ,
ICD-O-3
+∞
8.5
8
*
R21, ,
ICD-O-3
+∞
8.5
8
*
A01AB09, ,
ATC
miconazole; local oral
+∞
8.5
8
*
Z024, ,
ICD-O-3
+∞
8.5
8
*
N06AB04, ,
ATC
citalopram; systemic
+∞
8.5
8
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
8.5
8
*
L28, ,
ICD-O-3
+∞
8.5
8
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
8.5
8
*
WX882, ,
ICD-O-3
+∞
8.5
8
*
JN3CG, ,
ICD-O-3
+∞
8.5
8
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
8.5
8
*
R2110, ,
ICD-O-3
+∞
8.5
8
*
SPAT1260, ,
ICD-O-3
+∞
8.5
8
*
E780, ,
ICD-O-3
+∞
8.5
8
*
R05, ,
ICD-O-3
+∞
8.5
8
*
343, ,
Kela drug reimbursment
Pazopanib
+∞
8.5
8
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
8.5
8
*
R238, ,
ICD-O-3
+∞
8.5
8
*
B02AA02, ,
ATC
tranexamic acid; systemic
+∞
8.5
8
*
EBA10, ,
ICD-O-3
+∞
8.5
8
*
WX320, ,
ICD-O-3
+∞
8.5
8
*
QBB10, ,
ICD-O-3
+∞
7.4
7
*
D01AE16, ,
ATC
amorolfine; topical
+∞
7.4
7
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
7.4
7
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
7.4
7
*
ZXD20, ,
ICD-O-3
+∞
7.4
7
*
WF004, ,
ICD-O-3
+∞
7.4
7
*
WF049, ,
ICD-O-3
+∞
7.4
7
*
FM1BE, ,
ICD-O-3
+∞
7.4
7
*
A10BA02, ,
ATC
metformin; oral
+∞
7.4
7
*
ZXE05, ,
ICD-O-3
+∞
7.4
7
*
QX2XE, ,
ICD-O-3
+∞
7.4
7
*
SPAT1254, ,
ICD-O-3
+∞
7.4
7
*
NF1AA, ,
ICD-O-3
+∞
7.4
7
*
SPAT1156, ,
ICD-O-3
+∞
7.4
7
*
OAB43, ,
ICD-O-3
+∞
7.4
7
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
7.4
7
*
A09, ,
ICD-O-3
+∞
7.4
7
*
C03DA01, ,
ATC
spironolactone; oral
+∞
7.4
7
*
SBB10, ,
ICD-O-3
+∞
7.4
7
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
7.4
7
*
SPAT1305, ,
ICD-O-3
+∞
7.4
7
*
D7082, ,
ICD-10 Finland
Drug-induced neutropenia
+∞
7.4
7
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
7.4
7
*
SDE02, ,
ICD-O-3
+∞
7.4
7
*
Z718, ,
ICD-O-3
+∞
7.4
7
*
R06AX27, ,
ATC
desloratadine; oral
+∞
7.4
7
*
R91, ,
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
+∞
7.4
7
*
M02AA07, ,
ATC
piroxicam; topical
+∞
7.4
7
*
S04, ,
ICD-O-3
+∞
7.4
7
*
QB9S1, ,
ICD-O-3
+∞
7.4
7
*
C09CA06, ,
ATC
candesartan; oral
+∞
7.4
7
*
LC2AE, ,
ICD-O-3
+∞
7.4
7
*
QBE10, ,
ICD-O-3
+∞
7.4
7
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
7.4
7
*
M01AX17, ,
ATC
nimesulide; oral
+∞
7.4
7
*
C798, ,
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.4
7
*
I48, ,
ICD-10 Finland
Atrial fibrillation and flutter
+∞
7.4
7
*
L13, ,
ICD-O-3
+∞
7.4
7
*
C4914, ,
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder rhabdomyosarcoma
+∞
7.4
7
*
FM2CE, ,
ICD-O-3
+∞
7.4
7
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
7.4
7
*
ZZA00, ,
ICD-O-3
+∞
7.4
7
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
7.4
7
*
K0366, ,
ICD-10 Finland
Tooth plaque
+∞
7.4
7
*
K0510, ,
ICD-O-3
+∞
7.4
7
*
N17, ,
ICD-O-3
+∞
7.4
7
*
C4934, ,
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thoracic rhabdomyosarcoma
+∞
7.4
7
*
CJE20, ,
ICD-O-3
+∞
7.4
7
*
N05AH04, ,
ATC
quetiapine; oral
+∞
7.4
7
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
7.4
7
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
7.4
7
*
C10AX09, ,
ATC
ezetimibe; oral
+∞
6.3
6
*
SDE03, ,
ICD-O-3
+∞
6.3
6
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
6.3
6
*
N01, ,
ICD-O-3
+∞
6.3
6
*
Z023, ,
ICD-O-3
+∞
6.3
6
*
IAZ97, ,
ICD-O-3
+∞
6.3
6
*
ZXE06, ,
ICD-O-3
+∞
6.3
6
*
SPAT1230, ,
ICD-O-3
+∞
6.3
6
*
SAB01, ,
ICD-O-3
+∞
6.3
6
*
XLD00, ,
ICD-O-3
+∞
6.3
6
*
SPAT1144, ,
ICD-O-3
+∞
6.3
6
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
6.3
6
*
A04, ,
ICD-O-3
+∞
6.3
6
*
D07BA04, ,
ATC
hydrocortisone and antiseptics; topical
+∞
6.3
6
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
6.3
6
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
6.3
6
*
UGC12, ,
ICD-O-3
+∞
6.3
6
*
L15, ,
ICD-O-3
+∞
6.3
6
*
QDB10, ,
ICD-O-3
+∞
6.3
6
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
6.3
6
*
WX000, ,
ICD-O-3
+∞
6.3
6
*
K85, ,
ICD-O-3
+∞
6.3
6
*
SPAT1148, ,
ICD-O-3
+∞
6.3
6
*
290, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
6.3
6
*
DM1QA, ,
ICD-O-3
+∞
6.3
6
*
J01DA08, ,
ATC
[U] cefaclor
+∞
6.3
6
*
351, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
6.3
6
*
D07AB08, ,
ATC
desonide; topical
+∞
6.3
6
*
SPAT1283, ,
ICD-O-3
+∞
6.3
6
*
Z000, ,
ICD-10 Finland
General medical examination
+∞
6.3
6
*
H02AB07, ,
ATC
prednisone; oral
+∞
6.3
6
*
WZC20, ,
ICD-O-3
+∞
6.3
6
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
6.3
6
*
DM1AD, ,
ICD-O-3
+∞
6.3
6
*
K0365, ,
ICD-O-3
+∞
6.3
6
*
C4949, ,
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
6.3
6
*
EP1AE, ,
ICD-O-3
+∞
6.3
6
*
SPAT1043, ,
ICD-O-3
+∞
6.3
6
*
NE1BG, ,
ICD-O-3
+∞
6.3
6
*
L29, ,
ICD-O-3
+∞
6.3
6
*
QAE10, ,
ICD-O-3
+∞
6.3
6
*
ZXE15, ,
ICD-O-3
+∞
6.3
6
*
C09AA02, ,
ATC
enalapril; systemic
+∞
6.3
6
*
NE1DG, ,
ICD-O-3
+∞
6.3
6
*
SPAT1316, ,
ICD-O-3
+∞
6.3
6
*
OAB44, ,
ICD-O-3
+∞
6.3
6
*
ZXD30, ,
ICD-O-3
+∞
6.3
6
*
R5110, ,
ICD-O-3
+∞
6.3
6
*
3AA13, ,
ICD-O-3
+∞
6.3
6
*
207, ,
Kela drug reimbursment
Chronic arrhythmias
+∞
6.3
6
*
R101, ,
ICD-O-3
+∞
6.3
6
*
WX306, ,
ICD-O-3
+∞
6.3
6
*
SPAT1306, ,
ICD-O-3
+∞
6.3
6
*
AA1DG, ,
ICD-O-3
+∞
6.3
6
*
N05CD07, ,
ATC
temazepam; oral
+∞
6.3
6
*
WZC05, ,
ICD-O-3
+∞
6.3
6
*
G04BD12, ,
ATC
mirabegron; oral
+∞
6.3
6
*
NA3BG, ,
ICD-O-3
+∞
6.3
6
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
6.3
6
*
VALMI, ,
ICD-O-3
+∞
6.3
6
*
B01AF01, ,
ATC
rivaroxaban; oral
+∞
6.3
6
*
Z209, ,
ICD-10 Finland
Contact with and exposure to unspecified communicable disease
+∞
6.3
6
*
EP1CG, ,
ICD-O-3
+∞
6.3
6
*
ZXE02, ,
ICD-O-3
+∞
6.3
6
*
UKC02, ,
ICD-O-3
+∞
6.3
6
*
R229, ,
ICD-O-3
+∞
6.3
6
*
D11, ,
ICD-O-3
+∞
6.3
6
*
J010, ,
ICD-10 Finland
Acute maxillary sinusitis
+∞
6.3
6
*
E000001, ,
ATC
+∞
6.3
6
*
WX1BG, ,
ICD-O-3
+∞
6.3
6
*
NG1CG, ,
ICD-O-3
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
29
67
7.01
13.34
12.0
8.9
1.11
1.26
mmol/l
1.35
29
60
17
14
15.94
10.61
4.2
3.9
3.32
3.54
g/l
0.12
17
14
33
109
5.12
9.78
5.2
2.0
—
—
—
0
0
16
15
13.71
9.43
4.8
2.7
235.06
177.93
%
0.98
16
15
17
20
11.08
9.01
5.4
3.7
91.47
85.25
%
0.37
17
20
34
124
4.65
8.70
6.3
3.1
0.15
0.34
e6/l
0.84
27
91
20
52
5.11
7.67
1.6
1.7
—
—
—
0
0
20
52
5.11
7.67
1.7
1.7
—
—
—
0
0
42
196
4.23
7.38
5.4
2.4
—
—
—
0
0
35
156
3.69
6.33
6.3
3.0
—
—
—
0
0
22
74
3.98
5.96
1.8
1.7
—
—
—
0
0
22
75
3.92
5.84
6.4
3.2
2.75
1.67
e6/l
0.28
12
36
43
231
3.55
5.60
18.4
8.2
1.21
1.22
mmol/l
0.64
35
209
18
56
4.06
5.38
18.7
16.2
25.25
24.23
mmol/l
0.62
18
56
36
177
3.32
5.35
15.8
11.4
1.27
1.30
inr
—
9
49
21
74
3.71
5.26
6.7
3.2
0.70
4.20
e6/l
—
10
36
6
5
13.01
3.84
2.0
2.0
—
—
—
0
0
11
25
5.07
3.83
1.4
1.4
—
—
—
0
0
11
26
4.87
3.71
21.7
17.7
95.65
93.66
%
1.05
11
26
13
37
4.13
3.66
7.9
13.3
112.00
124.43
g/l
1.09
13
37
6
8
8.11
3.12
1.2
1.1
—
—
—
0
0
6
9
7.20
2.93
1.2
1.1
—
—
—
0
0
11
35
3.57
2.81
3.9
3.1
—
—
—
0
0
7
15
5.09
2.67
1.3
1.4
—
—
—
0
0
6
11
5.88
2.60
1.3
1.4
—
—
—
0
0
17
78
2.60
2.59
2.0
2.9
164.45
262.69
ng/l
0.21
11
53
6
12
5.38
2.46
1.2
1.2
—
—
—
0
0
5
9
5.91
2.25
1.4
2.2
—
—
—
0
0
5
9
5.91
2.25
1.4
2.1
—
—
—
0
0
6
14
4.60
2.20
3.0
1.4
21.00
83.11
u/ml
—
6
14
6
16
4.02
1.98
1.5
1.8
—
—
—
0
0
6
17
3.77
1.88
1.5
1.9
—
—
—
0
0
5
14
3.77
1.64
1.2
1.9
—
—
—
0
0
5
15
3.52
1.55
1.4
1.4
—
—
—
0
0
5
15
3.52
1.55
1.4
1.4
—
—
—
0
0
6
24
2.65
1.33
1.2
1.5
—
—
—
0
0
53
456
1.88
1.13
64.8
13.5
14.64
14.41
%
0.18
53
448
6
29
2.17
0.92
25.7
10.8
112.83
130.17
g/l
—
6
29
57
517
1.83
0.85
40.3
10.8
33.12
22.58
mg/l
1.35
50
376
30
236
1.50
0.82
8.6
4.5
0.00
0.00
estimate
—
8
40
50
439
1.60
0.80
33.5
9.1
89.90
85.76
ml/min/173m2
0.45
42
330
30
238
1.48
0.78
5.7
3.1
0.00
0.00
estimate
—
7
37
5
24
2.17
0.76
21.0
4.4
1.26
1.24
mmol/l
—
5
18
5
25
2.08
0.74
2.4
4.5
5.62
5.03
pmol/l
—
5
20
5
25
2.08
0.74
5.6
7.6
64.06
48.78
%
—
5
25
5
27
1.92
0.70
2.8
6.5
24.24
24.84
mmol/l
—
5
27
29
233
1.44
0.69
5.8
3.2
0.00
0.00
estimate
—
8
39
55
505
1.58
0.59
49.9
13.9
3.91
3.98
mmol/l
1.41
55
492
55
506
1.57
0.57
49.8
13.9
138.69
139.71
mmol/l
2.82
55
495
0
15
0.00
0.42
0.0
1.3
—
—
—
0
0
5
36
1.42
0.39
1.8
1.3
—
—
—
0
0
5
75
0.64
0.38
1.2
2.3
—
—
—
0
0
16
131
1.29
0.31
1.4
1.6
—
—
—
0
0
14
117
1.25
0.23
5.1
3.1
0.00
0.00
estimate
—
7
36
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
15
128
1.22
0.20
3.0
2.1
67.40
96.40
u/l
0.35
15
115
8
70
1.16
0.17
2.0
1.7
1.61
1.31
%
—
8
62
11
125
0.86
0.11
1.2
1.6
1.08
1.49
mmol/l
1.81
11
109
7
65
1.09
0.08
1.1
1.5
—
—
—
0
0
58
582
0.97
0.08
64.8
16.2
122.48
136.90
g/l
7.17
58
574
18
167
1.11
0.08
2.1
1.8
93.19
99.59
pmol/l
0.19
12
87
7
81
0.85
0.07
1.1
2.6
—
—
—
0
0
18
173
1.06
0.01
4.6
3.2
—
—
—
0
0
38
381
0.99
0.00
2.9
3.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.5
—
12.95
—
0
6
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
691.40
—
0
5
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
5
56
0.88
-0.00
4.6
6.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_RHABDOMYOSARCOMA_WIDE – Rhabdomyosarcoma, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).